FIONA PATEL: Open Payments
NPI 1629484167 · PROSPER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 41 payments from 18 companies in 2025. Trend: 2023 $247 · 2024 $308 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $123 |
| Novo Nordisk Inc | 5 | $112 |
| PFIZER INC. | 4 | $91 |
| Astellas Pharma US Inc | 4 | $70 |
| Lilly USA, LLC | 3 | $53 |
| Amgen Inc. | 3 | $51 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: Wegovy, VRAYLAR, Veozah, ELIQUIS, MOUNJARO, Auvelity, The Cologuard Plus Collection Kit, OTEZLA.
Industry payments across TX — which companies pay providers there.
